Chemotherapy of Burkitt's lymphoma.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine; D002051:Burkitt Lymphoma / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D002471:Cell Transformation, Neoplastic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D008727:Methotrexate / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D009607:Nitrosourea Compounds; D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate